SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cal Gary who wrote (13809)12/1/2004 1:51:58 AM
From: Cal Gary  Read Replies (1) of 14101
 
According www.arthritis.ca better known as the Arthris Society:

Pennsaid trials are being conducted in:
Ottawa ON
Etobicoke ON
Mississauga on
Barrie ON
Stoney Creek ON
London ON
North Bay ON
Newmarket ON
Hamilton ON
---------------------------------------------------
1. Combined Drug Treatment for Knee Osteoarthritis Relevance: 30%
Combined Drug Treatment for Knee Osteoarthritis Combined Drug Treatment for Knee Osteoarthritis Trial Location Ottawa, ON Brief Description
location: arthritis.ca:80/look%20at%20research/clinical%20trials/canadian%20cli
size: 30K · last modified: 29-Nov-2004
---------------------------------------------------
Combined Drug Treatment for Knee Osteoarthritis

Trial Location
Hamilton, Ontario


Brief Description

Pennsaid® is a prescription pain reliever that is applied to the skin. It is designed to act directly at the site of the pain, typically in one or both knees. People who take oral medication for arthritis, and still feel pain in their knee(s), may also want to add Pennsaid. This study is being done to evaluate the effects of using both treatments together.

The study will include approximately 750 patients. Participants must visit the study doctor five times over three months and make one phone-in report. The first visit should take about an hour; the others will take about 30 minutes each. The telephone call will take about 15 minutes.

Study Criteria (In order to qualify)

Participants Must:

be 40 to 85 years of age
be diagnosed with osteoarthritis in at least one knee
already be taking pain medication, regularly
be able to read and understand English
be able to swallow moderately sized tablets

Participants Must Not:

require knee surgery
be pregnant or breastfeeding

There are other exclusion criteria. Please contact the listed number for more information.

Contact Information

The study doctor will explain the risks and benefits of participating in this clinical trial. If you are interested, and would like further information, please call:

Anjali Pathak
Hamilton, ON
905-308-8319

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext